As indicated in prior research, PLK1 exhibits an association with unfavorable prognosis of patients in breast cancer [28], hepatocellular carcinoma [29], colorectal cancer, synovial sarcoma, lung adenocarcinoma and various other malignancies. This evidence concerns the gene PLK1 and hepatocellular carcinoma.